Company Description
Mach7 Technologs (OTC Link: TDMMF) is classified in the health information services industry within the Healthcare sector and carries a market capitalization of $117.6M.
TDMMF has declined 9.5% over the past year. Shares last traded at $0.2173.
This page collects what Stock Titan holds for TDMMF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Mach7 Technologs (TDMMF) stock last closed at $0.2173. Over the past 12 months, the stock has lost 9.5%. At a market capitalization of $117.6M, TDMMF is classified as a micro-cap stock with approximately 235.0M shares outstanding.
Latest News
Mach7 Technologs has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all TDMMF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Mach7 Technologs (TDMMF) currently stands at 250 shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. Since September 2025, short interest has decreased by 75.0%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Mach7 Technologs (TDMMF) currently stands at 5.0 days, down 9.1% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 100% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
TDMMF Company Profile & Sector Positioning
Mach7 Technologs (TDMMF) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing TDMMF often look at related companies in the same sector, including Hydreight Tech (HYDTF), NetraMark Holdings Inc (AINMF), Veradigm (MDRX), Kneat Com (KSIOF), and Treatment.com AI (TREIF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TDMMF's relative position within its industry.